Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	22.59	-30.36	-39.22
Graham Fair Price	64.14	84.02	51.19
PEG	81.90	-0.29	-1.60
Price/Book	-46.70	6.01	11.28
Price/Cash Flow	39.41	-34.21	-56.47
Prices/Earnings	14.93	-8.67	-10.19
Price/Sales	0.00	0.00	0.00
Price/FCF	39.41	-34.21	-56.47
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00
ROA	22.17	-0.14	-0.18
ROE	-0.28	-0.17	37.35
ROIC	-0.22	-0.16	30.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-16.48
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.19	-0.30	-57.25
EPS QOQ	-0.06	-0.30	-370.07
FCF QOQ	0.05	-0.85	1582.44
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	457.50	100.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.20	100.00
Debt/Capitalization	0.22	0.12	-45.80
Quick Ratio	5.35	9.26	73.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	20.51	42.53	107.37
Cash	32.09	52.95	65.00
Capex	-0.05	-0.02	65.96
Free Cash Flow	-4.10	-7.48	-82.43
Revenue	0.00	0.00	0.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.38	9.39	74.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.15	3.32	2151.46
Naive Interpretation	Member

06 - Financial Health · Bad

Rating